Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings ...

In addition to MERS, Regeneron’s proprietary antibody rapid response platform has been used to generate antibodies for Ebola virus and has the … Full Article http://j.gs/5sTq

Click here to read full article